Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Hal Mintz’

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Sophiris Bio Inc. (NASDAQ:SPHS): Sabby Capital Reports Large New Stake

Hal Mintz‘s Sabby Capital recently filed a Form 13G with the SEC, in which it reported the acquisition of 2.48 million common shares of Sophiris......(read more)
test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

13G Filing: Sabby Capital Opens Large Position in Rexahn Pharmaceuticals, Inc. (RNN)

Hal Mintz‘s Sabby Capital has revealed a new position in Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) through a 13G filing with the SEC. The position......(read more)
Warren Buffett and Billionaires

Buffett Buys More Shares of This Energy Company, Carlson Reaches Agreement With Vitamin Shoppe Inc. (VSI), Plus Two Other Moves

The HFRX Absolute Return Index, which measures the overall returns of the hedge fund industry, posted a negative return of 0.09% in 2015, which compares......(read more)
hxdbzxy/shutterstock.com

After Monster Q1, Hal Mintz’s Stock Picks Have Another Strong Quarter

Sabby Management is a New Jersey-based activist hedge fund launched by Hal Mintz in June 2011. The investment firm primarily employs an opportunistic......(read more)
health illness-signs

Healthcare Investing Maven Hal Mintz Just Opened A Big Position In This Biotech Firm

According to a 13G form filed with the Securities and Exchange Commission, Hal Mintz’s Sabby Management has acquired a new passive stake in OncoSec......(read more)
Acadia Healthcare Company Inc (NASDAQ:ACHC)

ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action......(read more)
Gevo, Inc. (NASDAQ:GEVO)

3 Stocks Hedge Funds Just Bought; Should You?

We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks. We’ll kick it......(read more)
digimarc-logo-black

Digimarc Corp (DMRC), Eleven Biotherapeutics Inc (EBIO): Rima Senvest Management and Sabby Management Are Bullish on These Micro-Caps

Digimarc Corp (NASDAQ:DMRC) and Eleven Biotherapeutics Inc (NASDAQ:EBIO) are two companies on which two funds have been bullish recently. Richard Mashaal......(read more)
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness. Not only did Steve Cohen’s Point72 Asset Management disclose......(read more)
Oplink Communications, Inc (NASDAQ:OPLK)

Lpath, Inc. (LPTN), Oplink Communications, Inc (OPLK): Sabby Management and Engaged Capital’s Latest SEC Filings

Hal Mintz‘s Sabby Management and Glenn W. Welling‘s Engaged Capital reported changes to their stakes in Lpath, Inc. (NASDAQ:LPTN) and Oplink......(read more)
Aastrom Biosciences

Aastrom Biosciences Inc (ASTM), The Providence Service Corporation (PRSC): Sabby Capital’s & Coliseum Capital’s Latest Moves

In two different filings with the U.S. Securities and Exchange Commission, Sabby Capital, led by Hal Mintz, reported initiating a new position in Aastrom......(read more)
StemCells Inc (NASDAQ:STEM)

Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM) And Skystar Bio-Pharmaceutical Company (SKBI)

Hal Mintz, the manager of Sabby Capital, believes StemCells Inc (NASDAQ:STEM) is a good investment and has opened a position for his fund. According......(read more)
RiceBran Technologies (NASDAQ:RIBT)

Sabby Capital Reveals New 7.3% Stake In RiceBran Technologies (RIBT)

RiceBran Technologies (NASDAQ:RIBT) has caught the attention of Hal Mintz, who has initiated a new position. In a recent filing with the Securities and......(read more)
Arthur B Cohen and Joseph Healey, Healthcor Management LP

Healthcor Management Initiates Exposure to Oxygen Biotherapeutics, Inc. (OXBT)

Arthur Cohen and Joseph Healey‘s Healthcor Management has added Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) to its equity portfolio. The fund revealed......(read more)

Adage Capital Management Discloses New Stake in OvaScience Inc (OVAS)

A new filing with the SEC shows that Phill Gross and  Robert Atchinson‘s Adage Capital Management has initiated a stake in OvaScience Inc (NASDAQ......(read more)
Oxygen Biotherapeutics

Hal Mintz, Sabby Management Report 7.43% Stake in Oxygen Biotherapeutics, Inc. (OXBT)

Hal Mintz‘ Sabby Management has reported a new stake in the biotechnology company Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT), a new filing with......(read more)
BiolineRX

Sabby Management Adds Bioline RX Ltd (BLRX) & Recro Pharma Inc (REPH) to Its Equity Portfolio

In a couple of new filings with the SEC, Hal Mintz‘s Sabby Management disclosed adding two companies to its equity portfolio: Bioline RX Ltd (NASDAQ......(read more)
OvaScience Inc (NASDAQ:OVAS)

Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)

Deerfield Management, led by James E. Flynn, revealed in a filing with the Securities and Exchange Commission that it has upped its stake in OvaScience......(read more)
Broadfin Kevin Kotler

Kevin Kotler’s Broadfin Capital Reports New Stake In MELA Sciences Inc (MELA)

Kevin Kotler’s Broadfin Capital, in its latest filing with the Securities and Exchange Commission, has reported ownership of 9.09 million shares of......(read more)
AdvaxisLogo[sm]

Make That 2 Biotech Stocks Today: Sabby Management Reveals It Bought Advaxis

Sabby Management, Advaxis: Advaxis, Inc. (NASDAQ:ADXS), a micro-cap biotech development company, has just seen Hal Mintz’s Sabby Management......(read more)
Dara Biosciences

Sabby Management Joins Alpha Capital Anstalt in DARA Biosciences With 8.3% Stake

Sabby Management, Dara Biosciences: In a new 13G filing just reported to the SEC, Hal Mintz’s Sabby Management reported an 8.3% stake in DARA Biosciences......(read more)